Skip to main content
Top

Rheumatology International

Issue 5/1997

Content (8 Articles)

Original Article

Tissue oxygen measurement and31P magnetic resonance spectroscopy in patients with muscle tension and fibromyalgia

E. -S. Strobel, M. Krapf, M. Suckfüll, W. Brückle, W. Fleckenstein, W. Müller

Original Article

Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis

E. M. Kittl, G. Haberhauer, R. Ruckser, S. Selleny, I. Rech-Weichselbraun, W. Hinterberger, K. Bauer

Original Article

Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR: Kinetics of stromelysin and IL-1 mRNA levels during arthritis

J. B. J. Van Meurs, P. L. E. M. Van Lent, L. A. B. Joosten, P. M. Van der Kraan, W. B. Van den Berg

Original Article

Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived fromMycoplasma arthritidis (MAS) and other mitogens

J. -M. Brand, P. Neustock, A. Kruse, L. Alvarez-Ossorio, A. Schnabel, H. Kirchner

Case Report

Lupus vulgaris in a patient with systemic lupus erythematosus and persistent IgG deficiency

N. Düzgün, M. Duman, B. Sonel, Y. Peksari, C. Erdem, G. Tokgöz

Letter to the Editor

Systemic lupus erythematosus arising in a patient with chronic silicosis

K. Özoran, H. Uçan, H. Tutkak, N. Caner, M. Yücel

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine